Equine - Gastric juice natural (Solution) Instructions for Use
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
ATC Code
A09AC02 (Polyenzyme acid-containing preparations)
Dosage Form
| Equine – Gastric juice natural | Oral solution: bottle 100 ml 1 pc. |
Dosage Form, Packaging, and Composition
| Oral solution | 1 L |
| Horse gastric juice | 100% |
| Salicylic acid | 200-400 mg |
100 ml – bottles (1) – cardboard packs.
Clinical-Pharmacological Group
Enzyme preparation
Pharmacotherapeutic Group
Digestive enzyme agent
Pharmacological Action
Enzyme preparation. It has a proteolytic effect. Product of animal origin (Horse gastric juice).
It contains all the enzymes of gastric juice. The content of free hydrochloric acid is 0.07-0.25%. As a preservative, the preparation contains salicylic acid 0.02-0.04%. Total acidity is 0.1-0.3%, pH 1.30-1.95.
Indications
- Achlorhydria – the absence of hydrochloric acid in the gastric juice.
- Hypoacid and anacid gastritis – forms of gastritis characterized by reduced or absent gastric acid secretion.
- Dyspepsia – indigestion or upset stomach, particularly when associated with insufficient digestive enzyme activity.
ICD codes
| ICD-10 code | Indication |
| K29 | Gastritis and duodenitis |
| K30 | Functional dyspepsia (digestive disorder) |
| K31.8 | Other specified diseases of stomach and duodenum |
| ICD-11 code | Indication |
| DA40.2 | Volvulus of stomach |
| DA41.0Z | Unspecified disorder of stomach motility |
| DA41.2 | Acid hyper secretion |
| DA41.3 | Achlorhydria |
| DA42.Z | Gastritis, unspecified |
| DA43.1 | Angiodysplasia of stomach |
| DA43.2 | Arteriovenous malformation of the stomach |
| DA43.3 | Gastropathy in portal hypertension |
| DA43.4 | Diffuse gastric vascular ectasia |
| DA4Y | Other specified diseases of the stomach |
| DA50.3 | Deformation of duodenum, acquired |
| DA51.Z | Duodenitis, unspecified |
| DA52.1 | Angiodysplasia of duodenum |
| DA52.2 | Arteriovenous malformation of duodenum |
| DA52.Y | Other specified vascular diseases of duodenum |
| DA7Z | Diseases of stomach or duodenum, unspecified |
| DD90.0 | Globus sensation |
| DD90.1 | Functional dysphagia |
| DD90.3 | Functional dyspepsia |
| DD90.Z | Functional disorders of esophagus or gastroduodenal system, unspecified |
| ME24.3Y | Other specified perforation in the area of the gastrointestinal tract |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer orally two to three times daily during or immediately after meals.
For adults, the dose is 15-30 ml (one to two tablespoons). For pediatric patients, adjust the dose based on age: for children under 3 years, administer 2.5-5 ml (half to one teaspoon); for children aged 3-6 years, administer 10 ml (two teaspoons); for children aged 7-14 years, administer 10-15 ml (one tablespoon).
Adverse Reactions
Gastrointestinal adverse reactions such as heartburn may occur.
Allergic reactions are possible, including skin rash, itching, or other hypersensitivity manifestations. Discontinue use if any adverse reactions develop.
Drug Interactions
Exercise caution with concomitant use of other acidic substances or agents that may affect gastric pH.
The preparation contains salicylic acid as a preservative; consider potential interactions with other salicylate-containing medications or drugs that may be affected by salicylates.
Contraindications
- Hypersensitivity to the active substance, salicylic acid, or any other component of the preparation.
- Contraindicated in patients with a known allergy to equine proteins or any animal-derived products.
- Avoid use in conditions where acidic agents are not recommended due to the preparation’s inherent acidity.
Overdose
Symptoms of overdose may include gastrointestinal discomfort, heartburn, or signs of salicylate toxicity due to the preservative content.
In case of suspected overdose, discontinue use immediately and initiate symptomatic and supportive treatment. There is no specific antidote; manage salicylate intoxication according to standard medical protocols if present.
Pediatric Use
Can be used in children according to indications.
Special Precautions
Quickly loses activity when stored in a warm place.
Storage Conditions
Store the drug out of reach of children, in a light-protected place at a temperature of 2 to 10°C (50°F).
Shelf Life
Shelf life – 1 year. Do not use after the expiration date printed on the package.
Dispensing Status
The drug is approved for use as an over-the-counter product.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer